Phosphoenix Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Investors
  • 11

Phosphoenix General Information

Description

Developer of a chronically implanted wireless device aimed at restoring functional and life-enhancing vision for individuals who have lost it. The company's device bypasses the eyes and establishes a direct interface with the brain, leveraging fundamental neuroscience insights to deliver practical clinical applications, enabling users to recognize objects, navigate more independently, and enjoy an elevated quality of life by restoring rudimentary vision.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Meibergdreef 5
  • Building APC, Room PCO-522
  • 1105 AZ Amsterdam
  • Netherlands
+31 06
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Meibergdreef 5
  • Building APC, Room PCO-522
  • 1105 AZ Amsterdam
  • Netherlands
+31 06

Phosphoenix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phosphoenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) Upcoming Product Development
7. Later Stage VC 18-Sep-2026 Completed Product Development
6. Seed Round 11-Dec-2024 Completed Product Development
5. Accelerator/Incubator 11-Dec-2024 Completed Product Development
4. Seed Round 22-Sep-2022 Completed Product Development
3. Grant 01-Sep-2020 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out Completed Startup
To view Phosphoenix’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phosphoenix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a chronically implanted wireless device aimed at restoring functional and life-enhancing vision for individ
Therapeutic Devices
Amsterdam, Netherlands
10 As of 2025

Valencia, CA
 

Alameda, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phosphoenix Competitors (4)

One of Phosphoenix’s 4 competitors is Cortigent, a Pending Transaction (M&A) company based in Valencia, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cortigent Pending Transaction (M&A) Valencia, CA
Science (Therapeutic Devices) Venture Capital-Backed Alameda, CA
Neuralink Venture Capital-Backed Fremont, CA
Vivani Medical Formerly VC-backed Alameda, CA
To view Phosphoenix’s complete competitors history, request access »

Phosphoenix Patents

Phosphoenix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4536340-B1 High density brain electrode assembly for read-out and/or stimulation of brain tissue Active 13-Jun-2022
US-20260241158-A1 High density brain electrode assembly for read-out and/or stimulation of brain tissue Pending 13-Jun-2022
EP-4536340-A1 High density brain electrode assembly for read-out and/or stimulation of brain tissue, for example a high density brain read-out and/or stimulation electrode assembly to read-out and/or stimulate a lateral geniculate nucleus of the thalamus to create visual perceptions in a mammal Active 13-Jun-2022
JP-2025522376-A High density brain electrode assembly for reading out and/or stimulating brain tissue - patents.com Pending 13-Jun-2022 A61N1/36103

Phosphoenix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phosphoenix Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
ROM InWest Asset Manager Minority
Creative Destruction Lab Accelerator/Incubator
First Fund Venture Capital Minority
University of Toronto Entrepreneurship Accelerator/Incubator
BioGeneration Ventures Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Phosphoenix FAQs

  • When was Phosphoenix founded?

    Phosphoenix was founded in 2019.

  • Where is Phosphoenix headquartered?

    Phosphoenix is headquartered in Amsterdam, Netherlands.

  • What is the size of Phosphoenix?

    Phosphoenix has 10 total employees.

  • What industry is Phosphoenix in?

    Phosphoenix’s primary industry is Therapeutic Devices.

  • Is Phosphoenix a private or public company?

    Phosphoenix is a Private company.

  • What is Phosphoenix’s current revenue?

    The current revenue for Phosphoenix is .

  • How much funding has Phosphoenix raised over time?

    Phosphoenix has raised $1.51M.

  • Who are Phosphoenix’s investors?

    ROM InWest, Creative Destruction Lab, First Fund, University of Toronto Entrepreneurship, and BioGeneration Ventures are 5 of 11 investors who have invested in Phosphoenix.

  • Who are Phosphoenix’s competitors?

    Cortigent, Science (Therapeutic Devices), Neuralink, and Vivani Medical are competitors of Phosphoenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process